PLOD2 and breast carcinoma: Accordingly, PLOD2, a well-known risk gene for breast cancer patients [27, 45], as it stimulates EMT in cancer [26, 46] is triggered by hypoxia in both luminal cells and more abundantly in basal A cells in our study.